Century Therapeutics, Inc. (53) | Business Finance (18)

Browse by Subcategory

Recent Contracts

Amendment No. 1 to Loan and Security Agreement, by and between Century Therapeutics, Inc. and Hercules Capital, Inc., dated May 13, 2022 (Filed With SEC on August 11, 2022)
Securities Purchase Agreement, by and between Century Therapeutics, Inc. and Bristol-Myers Squibb Company, dated January 7, 2022 (Filed With SEC on January 10, 2022)
2021 Employee Stock Purchase Plan (Filed With SEC on June 14, 2021)
Form of Underwriting Agreement (Filed With SEC on June 14, 2021)
Investors Rights Agreement, by and among the Registrant and each of the investors listed on Schedule A thereto, dated February 25, 2021 (Filed With SEC on May 28, 2021)
Warrant to Purchase Units of Century Therapeutics, LLC, in favor of Hercules Technology Management Co II, Inc., dated September 14, 2020 (Filed With SEC on May 28, 2021)
Specimen Common Stock Certificate of Registrant (Filed With SEC on June 14, 2021)
Form of Stock Option Grant Notice and Award Agreement, under the 2021 Plan (Filed With SEC on May 28, 2021)
Loan and Security Agreement, by and between Century Therapeutics, Inc. and Hercules Capital, Inc (Filed With SEC on May 28, 2021)
Form of Restricted Stock Unit Grant Notice and Award Agreement, under the 2021 Plan (Filed With SEC on May 28, 2021)
Form of Restricted Stock Award Agreement, under the 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Amendment No. 5 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Amendment No. 4 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Amendment No. 3 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Amendment No. 2 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Amendment No. 1 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Form of Non-Qualified Stock Option Agreement, under the 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)